The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo
Grace, M S, Lieu, T, Darby, B, Abogadie, F C, Veldhuis, N, Bunnett, N W, McIntyre, PVolume:
171
Language:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.12750
Date:
August, 2014
File:
PDF, 1.57 MB
english, 2014